In contrast, other experiments have shown that anti-TIM-3 mAb alone exerted an antitumor effect on WT3 sarcoma, a MC38 tumor, and B16 melanoma models [41, 131, 137]. This evidence concerns the gene HAVCR2 and neoplasm.